An Overview of Surgical Management of Portal Hypertension in Children

Abstract

Pediatric portal hypertension is a relatively rare but a life-threatening problem. With advancements in understanding of portal hypertension physiology and lessons learned from management in adults, medical management is playing an increasing role. However, certain conditions are amenable to surgical management. Key considerations for surgical options are state of liver parenchyma and preservation of liver function. In cases of extrahepatic portal vein obstruction, Meso-Rex bypass or shunt can offer a long-term solution. Similarly in select group of patients, selective or central shunts can be considered. With advancement in liver transplantation, there are very few indications for non-transplant surgical procedures for the management of portal hypertension.

Keywords

pediatric portal hypertension - portosystemic shunts - surgical treatment of portal - hypertension

Financial Disclosure

Authors have no financial disclosure.

Publikationsverlauf

Eingereicht: 21. Februar 2024

Angenommen: 22. Februar 2024

Artikel online veröffentlicht:
02. April 2024

• References

• 1 Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16 (48) 6046-6057
• 2 Kawada N, Tran-Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993; 213 (02) 815-823
• 3 Iwakiri Y, Kim MY. Nitric oxide in liver diseases. Trends Pharmacol Sci 2015; 36 (08) 524-536
• 4 Ballet F, Chretien Y, Rey C, Poupon R. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. J Pharmacol Exp Ther 1988; 244 (01) 283-289
• 5 Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43 (2, Suppl 1): S121-S131
• 6 Kim MY, Baik SK. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension]. Korean J Gastroenterol 2009; 54 (03) 143-148
• 7 Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int 2018; 38 (04) 570-580
• 8 Nobre S, Khanna R, Bab N. et al. Primary Budd-Chiari syndrome in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr 2017; 65 (01) 93-96
• 9 Samanta A, Sen Sarma M, Yadav R. Budd-Chiari syndrome in children: challenges and outcome. World J Hepatol 2023; 15 (11) 1174-1187
• 10 Mukhiya G, Zhou X, Han X. et al. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis. Sci Rep 2022; 12 (01) 16166
• 11 Garmpis N, Damaskos C, Prevezanos D. et al. Liver transplantation and Budd-Chiari syndrome: when the cause becomes the solution. Maedica (Buchar) 2022; 17 (02) 415-419
• 12 Emamaullee J, Zaidi AN, Schiano T. et al. Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 2020; 142 (06) 591-604
• 13 Maruyama H, Yokosuka O. Ultrasonography for noninvasive assessment of portal hypertension. Gut Liver 2017; 11 (04) 464-473
• 14 de Franchis R, Faculty BV. Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
• 15 de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33 (05) 846-852
• 16 Groszmann RJ, Bosch J, Grace ND. et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99 (05) 1401-1407
• 17 Duché M, Ducot B, Tournay E. et al. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology 2010; 139 (06) 1952-1960
• 18 Giefer MJ, Murray KF, Colletti RB. Pathophysiology, diagnosis, and management of pediatric ascites. J Pediatr Gastroenterol Nutr 2011; 52 (05) 503-513
• 19 Karnsakul W, Ingviya T, Seaberg E. et al. Ascites in children: a single-center experience of 27 years. J Pediatr Gastroenterol Nutr 2017; 64 (01) 83-88
• 20 Mohammad S, Kaurs E, Aguirre VP, Varni JW, Alonso EM. Health-related quality of life in infants with chronic liver disease. J Pediatr Gastroenterol Nutr 2016; 62 (05) 751-756
• 21 Pugliese R, Fonseca EA, Porta G. et al. Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure. Hepatology 2014; 59 (05) 1964-1971
• 22 Mahajan S, Lal BB, Sood V, Khillan V, Khanna R, Alam S. Difficult-to-treat ascetic fluid infection is a predictor of transplant-free survival in childhood decompensated chronic liver disease. Indian J Gastroenterol 2020; 39 (05) 465-472
• 23 Bolia R, Srivastava A, Marak R, Yachha SK, Poddar U. Prevalence and impact of bacterial infections in children with liver disease - a prospective study. J Clin Exp Hepatol 2018; 8 (01) 35-41
• 24 Sharma P, Sharma BC, Puri V, Sarin SK. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008; 103 (06) 1406-1412
• 25 Srivastava A, Chaturvedi S, Gupta RK. et al. Minimal hepatic encephalopathy in children with chronic liver disease: prevalence, pathogenesis and magnetic resonance-based diagnosis. J Hepatol 2017; 66 (03) 528-536
• 26 Pinto RB, Schneider AC, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol 2015; 7 (03) 392-405
• 27 de Ville de Goyet J, Alberti D, Clapuyt P. et al. Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension. J Pediatr Surg 1998; 33 (04) 597-601
• 28 Chen VT, Wei J, Liu YC. A new procedure for management of extrahepatic portal obstruction. Proximal splenic-left intrahepatic portal shunt. Arch Surg 1992; 127 (11) 1358-1360
• 29 Chiu B, Pillai SB, Sandler AD, Superina RA. Experience with alternate sources of venous inflow in the Meso-Rex bypass operation: the coronary and splenic veins. J Pediatr Surg 2007; 42 (07) 1199-1202
• 30 Ateş O, Hakgüder G, Olguner M, Akgür FM. Extrahepatic portal hypertension treated by anastomosing inferior mesenteric vein to left portal vein at Rex recessus. J Pediatr Surg 2003; 38 (10) E10-E11
• 31 Lv Y, Pu L, Song J. et al. Meso-Rex bypass shunt vs. transposition shunt for cavernous transformation of portal vein in children. Front Pediatr 2022; 10: 935828
• 32 de Ville de Goyet J, Lo Zupone C, Grimaldi C. et al. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives. Pediatr Transplant 2013; 17 (01) 19-26
• 33 Mack CL, Zelko FA, Lokar J. et al. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability. Pediatrics 2006; 117 (03) e405-e412
• 34 Chiu B, Superina R. Extrahepatic portal vein thrombosis is associated with an increased incidence of cholelithiasis. J Pediatr Surg 2004; 39 (07) 1059-1061
• 35 Sarin SK, Guptan RC, Malhotra S. Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension. J Assoc Physicians India 2002; 50: 518-522
• 36 Chaudhary A, Dhar P, Sarin SK. et al. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg 1998; 85 (03) 326-329
• 37 Rangari M, Gupta R, Jain M, Malhotra V, Sarin SK. Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 2003; 23 (06) 434-439
• 38 de Ville de Goyet J, D'Ambrosio G, Grimaldi C. Surgical management of portal hypertension in children. Semin Pediatr Surg 2012; 21 (03) 219-232
• 39 Warren WD, Salam AA, Hutson D, Zeppa R. Selective distal splenorenal shunt. Technique and results of operation. Arch Surg 1974; 108 (03) 306-314
• 40 Moon SB, Jung SE, Ha JW, Park KW, Seo JK, Kim WK. The usefulness of distal splenorenal shunt in children with portal hypertension for the treatment of severe thrombocytopenia and leukopenia. World J Surg 2008; 32 (03) 483-487
• 41 Jenkins RL, Gedaly R, Pomposelli JJ, Pomfret EA, Gordon F, Lewis WD. Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation. Arch Surg 1999; 134 (04) 416-420
• 42 Linton RR, Ellis DS, Geary JE. Critical comparative analysis of early and late results of splenorenal and direct portacaval shunts performed in 169 patients with portal cirrhosis. Ann Surg 1961; 154 (03) 446-459
• 43 Mitra SK, Rao KL, Narasimhan KL. et al. Side-to-side lienorenal shunt without splenectomy in noncirrhotic portal hypertension in children. J Pediatr Surg 1993; 28 (03) 398-401 , discussion 401–402
• 44 Sarfeh IJ, Rypins EB, Conroy RM, Mason GR. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983; 197 (04) 422-426
• 45 Tainaka T, Hinoki A, Tanaka Y. et al. Long-term outcomes of the partial splenectomy for hypersplenism after portoenterostomy of patients with biliary atresia. Nagoya J Med Sci 2021; 83 (04) 765-771
• 46 Chen J, Yu S, Xu L. Laparoscopic partial splenectomy: a safe and feasible treatment for splenic benign lesions. Surg Laparosc Endosc Percutan Tech 2018; 28 (05) 287-290
• 47 Amin MA, el-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg 2009; 33 (08) 1702-1710
• 48 Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg 1973; 66 (05) 677-685
• 49 Shah SR, Nagral SS, Mathur SK. Results of a modified Sugiura's devascularisation in the management of “unshuntable” portal hypertension. HPB Surg 1999; 11 (04) 235-239
• 50 Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-676
• 51 Bismuth H, Houssin D. Reduced-sized orthotropic liver graft in hepatic transplantation in children. Surgery 1984; 95 (03) 367-370
• 52 Broelsch CE, Emond JC, Thistlethwaite JR, Rouch DA, Whitington PF, Lichtor JL. Liver transplantation with reduced-size donor organs. Transplantation 1988; 45 (03) 519-524
• 53 Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. [Transplantation of a donor liver to 2 recipients (splitting transplantation) – a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir 1988; 373 (02) 127-130
• 54 Bismuth H, Morino M, Castaing D. et al. Emergency orthotropic liver transplantation in two patients using one donor liver. Br J Surg 1989; 76 (07) 722-724
• 55 Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989; 2 (8661): 497
• 56 Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322 (21) 1505-1507
• 57 McDiarmid SV, Anand R, Lindblad AS. Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002; 74 (02) 173-181
• 58 Mogul DB, Luo X, Bowring MG. et al. Fifteen-year trends in pediatric liver transplants: split, whole deceased, and living donor grafts. J Pediatr 2018; 196: 148-153.e2
• 59 McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates under the PELD system. Liver Transpl 2004; 10 (10, Suppl 2): S23-S30
• 60 Goldaracena N, Echeverri J, Kehar M. et al. Pediatric living donor liver transplantation with large-for-size left lateral segment grafts. Am J Transplant 2020; 20 (02) 504-512
• 61 Ma N, Song Z, Dong C. et al. Risk factors of hepatic artery thrombosis in pediatric deceased donor liver transplantation. Pediatr Surg Int 2019; 35 (08) 853-859
• 62 Martinez M, Kang E, Beltramo F. et al. Vascular thrombosis after pediatric liver transplantation: Is prevention achievable?. J Liver Transpl 2023; 12: 100185
• 63 SRTR. Accessed January 16, 2024 at: https://srtr.transplant.hrsa.gov/annual_reports/2020/Liver.aspx
• 64 Bowring MG, Massie AB, Chu NM. et al. Projected 20- and 30-year outcomes for pediatric liver transplant recipients in the United States. J Pediatr Gastroenterol Nutr 2020; 70 (03) 356-363
• 65 Shingina A, Vutien P, Uleryk E. et al. Long-term outcomes of pediatric living versus deceased donor liver transplantation recipients: a systematic review and meta-analysis. Liver Transpl 2022; 28 (03) 437-453